12 April 2017 - The opinion relates the use of pembrolizumab by patients with non-small-cell lung cancer. ...
31 March 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
20 March 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
3 March 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
10 February 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
3 February 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
18 January 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
6 January 2017 - HAS has posted the agenda for the first Transparency Commission meeting for 2017. ...
2 December 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
24 November 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
22 October 2016 - The Transparency Committee, responsible for evaluating medicinal products within the High Authority of Health recommended against ...
12 October 2016 - HAS has published the agenda for the next scheduled Transparency Commission meeting. ...
28 September 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
26 September 2016 - The Transparency Commission has published its opinion on Sanofi's GLP-1 analogue. ...
19 September 2016 - The Transparency Commission will consider the reimbursement of a number of new medicines and blood products. ...